German Pharmaceuticals & Biotech Potentially Undervalued Companies

Aspen Pharmacare Holdings

Market Cap: €44.9b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

Charles River Laboratories International

Market Cap: €7.5b

Charles River Laboratories International, Inc.

Agenus

Market Cap: €145.0m

A clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally.

GSK

Market Cap: €59.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Shionogi

Market Cap: €2.3t

Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.

Bristol-Myers Squibb

Market Cap: €93.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

GSK

Market Cap: €59.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Plus Therapeutics

Market Cap: €5.1m

A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.

Citius Pharmaceuticals

Market Cap: €15.5m

A biopharmaceutical company, focuses on the development and commercialization of critical care products.

Adaptimmune Therapeutics

Market Cap: €21.4m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Pharming Group

Market Cap: €814.6m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

iAnthus Capital Holdings

Market Cap: €67.8m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Gerresheimer

Market Cap: €1.5b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Bio-Rad Laboratories

Market Cap: €7.4b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Zai Lab

Market Cap: €3.6b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Cellectis

Market Cap: €200.3m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Tecan Group

Market Cap: €2.0b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Cardiff Oncology

Market Cap: €133.7m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

Clinuvel Pharmaceuticals

Market Cap: €577.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Waters

Market Cap: €18.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

AC Immune

Market Cap: €243.4m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

SCHOTT Pharma KGaA

Market Cap: €3.3b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

Ironwood Pharmaceuticals

Market Cap: €207.9m

A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.

Genmab

Market Cap: €109.4b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Collegium Pharmaceutical

Market Cap: €1.1b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Illumina

Market Cap: €15.5b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Planet 13 Holdings

Market Cap: €99.2m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Pharming Group

Market Cap: €814.6m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Xenon Pharmaceuticals

Market Cap: €2.8b

A neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada.

Santen Pharmaceutical

Market Cap: €539.6b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Valneva

Market Cap: €732.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Adagene

Market Cap: €96.1m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Thermo Fisher Scientific

Market Cap: €178.5b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Zoetis

Market Cap: €65.1b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Oncodesign Precision Medicine Société anonyme

Market Cap: €11.8m

A biopharmaceutical company, engages in the precision medicine business.

Indivior

Market Cap: €2.4b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.